Spots Global Cancer Trial Database for Feasibility of Holmium-166 Micro Brachytherapy in Head and Neck Tumors

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Feasibility of Holmium-166 Micro Brachytherapy in Head and Neck Tumors

Official Title: Feasibility of Holmium-166 Microspheres for Selective Intra-tumoural Treatment in Head and Neck Cancer: Biodistribution and Safety in Patients With Malignancy of the Tongue

Study ID: NCT02975739

Conditions

Radioisotopes

Head and Neck Neoplasms

Interventions

Holmium-166 (poly L lactic acid) microspheres

Study Description

Brief Summary: The main objective is to establish the feasibility of 166-Holmium microspheres for intratumoral injections in oral squamous cell carcinoma (OSCC) of the tongue. Participants will receive intratumoral injections with a low radioactive 166-Holmium microspheres followed by surgical resection

Detailed Description: 166-Holmium microspheres poly lactic acid microspheres are currently used in selective internal radiation therapy. These microspheres emits beta radiation. The majority of the radiation dose will be absorbed within 3.2 mm with a maximum penetration in tissue of 9 mm. Therefore this can result in a high local tumor ablative dose with minimal dose to healthy adjacent tissue.